« Statins may curb multiple sclerosis | Main | Cannabis Spray To Treat Multiple Sclerosis »

Clinical Trial Investigates Treatment of Multiple Sclerosis With Gamunex(R), Immune Globulin Intravenous (Human), 10% Caprylate/Chromatography Purified

Bayer HealthCare LLC, Biological Products Division (Bayer BP), has closed enrollment in the first industry-sponsored trial to evaluate immune globulin intravenous (IGIV) for the treatment of relapsing-remitting multiple sclerosis (RRMS). Under an Investigational New Drug application (IND) submitted to the U.S. Food and Drug Administration (FDA), the multi-national clinical trial will assess the efficacy and safety of Gamunex?, Immune Globulin Intravenous (Human), 10% Caprylate/Chromatography Purified, in RRMS. The study includes 120 patients participating from many regions of the world, including North America, eastern and western Europe, and Israel.

More here.

May 16, 2004 in research | Permalink

Comments